Active Ingredient: RILUZOLE
Proprietary Name: EXSERVAN
Dosage Form; Route of Administration: FILM; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N212640
Product Number: 001
Approval Date: Nov 22, 2019
Applicant Holder Full Name: AQUESTIVE THERAPEUTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information